PNC Financial Services Group’s Aldeyra Therapeutics ALDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.07K | Buy |
541
+447
| +476% | +$1.71K | ﹤0.01% | 4397 |
|
|
2025
Q1 | $541 | Buy |
94
+60
| +176% | +$345 | ﹤0.01% | 4627 |
|
|
2024
Q4 | $170 | Hold |
34
| – | – | ﹤0.01% | 4661 |
|
|
2024
Q3 | $183 | Hold |
34
| – | – | ﹤0.01% | 4686 |
|
|
2024
Q2 | $113 | Buy |
+34
| New | +$113 | ﹤0.01% | 4712 |
|
|
2023
Q3 | – | Sell |
-246
| Closed | -$2.06K | – | 4608 |
|
|
2023
Q2 | $2.06K | Hold |
246
| – | – | ﹤0.01% | 4373 |
|
|
2023
Q1 | $2.44K | Hold |
246
| – | – | ﹤0.01% | 4257 |
|
|
2022
Q4 | $1.71K | Hold |
246
| – | – | ﹤0.01% | 4298 |
|
|
2022
Q3 | $1K | Buy |
+246
| New | +$1K | ﹤0.01% | 4279 |
|
|
2022
Q2 | – | Sell |
-40
| Closed | – | – | 4460 |
|
|
2022
Q1 | $0 | Buy |
+40
| New | – | ﹤0.01% | 4500 |
|
|
2021
Q4 | – | Sell |
-248
| Closed | -$2K | – | 4426 |
|
|
2021
Q3 | $2K | Buy |
248
+197
| +386% | +$1.59K | ﹤0.01% | 4077 |
|
|
2021
Q2 | $1K | Buy |
+51
| New | +$1K | ﹤0.01% | 4083 |
|